Allan G. Beniashvili
Moscow, MOW, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Clinical experience with melatonin and memantine combination (Miladean) in children with cognitive and behavioral impairments
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Published: March 05, 2026
New Opportunities in the Treatment of Moderate Cognitive Impairment: Results of the Millennium Study in Real Clinical Practice
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Published: January 12, 2026
Cognitive impairment in patients with chronic heart failure and its impact on adherence to treatment
Cognitive impairment in patients with chronic heart failure and its impact on adherence to treatment
Journal: Terapevticheskii arkhiv
Published: January 28, 2025
The technology of induction of physiological ketosis in asthenia of various origins and decreased resistance to cognitive and physical activity
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Published: November 22, 2024
Barth syndrome in an adult patient: an overview of the problem and case report. A review
Journal: Terapevticheskii arkhiv
Published: July 21, 2024
Efficacy of a Relaxation Scenario in Virtual Reality for the Comorbid Symptoms of Anxiety and Asthenia in a General Hospital Setting: A Pilot Comparative Randomized Open-Label Study.
Journal: Consortium psychiatricum
Published: October 28, 2022
Low doses of quetiapine (Seroquel) as an impulsivity corrector in patients with bipolar affective disorder in remission
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Published: August 29, 2022
Development of Peptide Biopharmaceuticals in Russia.
Journal: Pharmaceutics
Published: January 12, 2022
An effect of cholinesterase blockade on negative symptoms in schizophrenia
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Published: September 05, 2021
Effects of the drug combination memantine and melatonin on impaired memory and brain neuronal deficits in an amyloid-predominant mouse model of Alzheimer's disease.
Journal: The Journal of pharmacy and pharmacology
Published: June 17, 2019
Last Updated: 09/26/2026